Sphingosine-1-Phosphate Signaling in Ischemic Stroke: From Bench to Bedside and Beyond

Sphingosine-1-Phosphate Signaling in Ischemic Stroke: From Bench to Bedside and Beyond

Sphingosine-1-phosphate (S1P) signaling is being increasingly recognized as a strong modulator of immune cell migration and endothelial function. Fingolimod and other S1P modulators in ischemic stroke treatment have shown promise in emerging experimental models and small-scale clinical trials. In th...

Full description

Bibliographic Details
Main Authors:	Shuo-Qi Zhang, Jun Xiao, Man Chen, Luo-Qi Zhou, Ke Shang, Chuan Qin, Dai-Shi Tian
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	sphingosine-1-phosphate ischemic stroke fingolimod neuroprotective agent translational research
Online Access:	https://www.frontiersin.org/articles/10.3389/fncel.2021.781098/full

Similar Items

Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
by: Sara Grassi, et al.
Published: (2019-07-01)

Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
by: Alessandro Cannavo, et al.
Published: (2017-08-01)

Acquired modification of sphingosine-1-phosphate lyase activity is not related to adrenal insufficiency
by: Gulin Sunter, et al.
Published: (2018-04-01)

Sphingosine-1-Phosphate Modulates Dendritic Cell Function: Focus on Non-Migratory Effects in Vitro and in Vivo
by: Olga Arlt, et al.
Published: (2014-06-01)

The emerging role of FTY720 as a sphingosine 1‐phosphate analog for the treatment of ischemic stroke: The cellular and molecular mechanisms
by: Maryam Naseh, et al.
Published: (2021-06-01)

Effect of FTY720 inhibiting corneal neovascularition induced by sphingosine 1-phosphate
by: Fan Zhong, et al.
Published: (2015-07-01)

Roles of sphingosine-1-phosphate signaling in cancer
by: Peng Wang, et al.
Published: (2019-11-01)

The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
by: Kana Masuda-Kuroki, et al.
Published: (2023-09-01)

Activation-induced cell death of dendritic cells is dependent on sphingosine kinase 1
by: Anja eSchwiebs, et al.
Published: (2016-04-01)

Association of Plasma Metabolic Biomarker Sphingosine-1-Phosphate With Cerebral Collateral Circulation in Acute Ischemic Stroke
by: Fang Yu, et al.
Published: (2021-08-01)

Neurological Consequences of Sphingosine Phosphate Lyase Insufficiency
by: Krishan B. Atreya, et al.
Published: (2022-09-01)

Sphingosine 1-Phosphate Signaling at the Skin Barrier Interface
by: Kana Masuda-Kuroki, et al.
Published: (2022-05-01)

Sphingosine-1-Phosphate Signaling in Cardiovascular Diseases
by: Na Wang, et al.
Published: (2023-05-01)

Sphingosine 1-Phosphate Receptor 4 Expression in Colorectal Cancer Patients
by: Suchittra SAMUHASANEETO, et al.
Published: (2016-06-01)

Sphingosine-1-Phosphate: Boon and Bane for the Brain
by: Gerhild van Echten-Deckert, et al.
Published: (2014-06-01)

A Sphingosine 1-Phosphate Gradient Is Linked to the Cerebral Recruitment of T Helper and Regulatory T Helper Cells during Acute Ischemic Stroke
by: Alexandra Lucaciu, et al.
Published: (2020-08-01)

Neuronal Metabolism and Neuroprotection: Neuroprotective Effect of Fingolimod on Menadione-Induced Mitochondrial Damage
by: Antonio Gil, et al.
Published: (2020-12-01)

High-Energy Phosphates and Ischemic Heart Disease: From Bench to Bedside
by: Hao Yi-Dan, et al.
Published: (2021-07-01)

HIV-1 Infection Results in Sphingosine-1-Phosphate Receptor 1 Dysregulation in the Human Thymus
by: Rachel S. Resop, et al.
Published: (2023-09-01)

Fifty years of lyase and a moment of truth: sphingosine phosphate lyase from discovery to disease[S]
by: Julie D. Saba
Published: (2019-03-01)

Targeting Sphingosine 1-Phosphate Metabolism as a Therapeutic Avenue for Prostate Cancer
by: Saida Mebarek, et al.
Published: (2023-05-01)

The effect of Fingolimod on patients with moderate to severe COVID‐19
by: Soheil Teymouri, et al.
Published: (2023-02-01)

Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
by: Burcu Altunrende, et al.
Published: (2017-12-01)

Role of Sphingosine-1-Phosphate in Mast Cell Functions and Asthma and Its Regulation by Non-Coding RNA
by: Rohit Saluja, et al.
Published: (2017-05-01)

Sphingosine 1-Phosphate Signaling and Metabolism in Chemoprevention and Chemoresistance in Colon Cancer
by: Petra Grbčić, et al.
Published: (2020-05-01)

Sphingosine 1-Phosphate and Cancer: Lessons from Thyroid Cancer Cells
by: Kid Törnquist
Published: (2013-05-01)

Irisin Is Target of Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor-Mediated Signaling in Skeletal Muscle Cells
by: Federica Pierucci, et al.
Published: (2023-06-01)

The Anti-Infectious Role of Sphingosine in Microbial Diseases
by: Yuqing Wu, et al.
Published: (2021-05-01)

Sphingosine kinase/sphingosine 1-phosphate axis: a new player for insulin-like growth factor-1-induced myoblast differentiation
by: Bernacchioni Caterina, et al.
Published: (2012-07-01)

Role of sphingosine 1-phosphate (S1P) and effects of fingolimod, an S1P receptor 1 functional antagonist in lymphocyte circulation and autoimmune diseases
by: Kenji Chiba, et al.
Published: (2014-11-01)

Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation
by: Alessandra Roggeri, et al.
Published: (2020-10-01)

Does the Sphingosine 1-Phosphate Receptor-1 Provide a Better or Worse Prognostic Outcome for Breast Cancer Patients?
by: Nigel J. Pyne, et al.
Published: (2018-09-01)

Sphingosine-1 Phosphate Lyase Regulates Sensitivity of Pancreatic Beta-Cells to Lipotoxicity
by: Yadi Tang, et al.
Published: (2021-10-01)

Are different degrees of lymphopenia for FTY720 associated with serious infectious-type events? No
by: Catalina Márquez-Martín, et al.
Published: (2022-07-01)

Intracellular localization of sphingosine kinase 1 alters access to substrate pools but does not affect the degradative fate of sphingosine-1-phosphate[S]
by: Deanna L. Siow, et al.
Published: (2010-09-01)

The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of <i>NR4A</i> Genes in Microglia Cell Line
by: Francesca Montarolo, et al.
Published: (2022-03-01)

Corrigendum: Sphingosine 1-Phosphate: A Novel Target for Lung Disorders
by: Sabira Mohammed, et al.
Published: (2018-07-01)

Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice
by: Anabel S. De la Garza-Rodea, et al.
Published: (2022-07-01)

Commentary: Sphingosine-1-phosphate inhibitors are potential therapeutic targets for pulmonary arterial hypertension
by: Naga P Bhavanam, et al.
Published: (2015-10-01)

Pathogenic sphingosine 1-phosphate pathway in psoriasis: a critical review of its pathogenic significance and potential as a therapeutic target
by: Yuechun Zhao, et al.
Published: (2023-04-01)